•  
  •  
  •  
  •  

2025-10-07 11:49:23

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  AKIIndia

Stock Report

  • Huhtamaki India Ltd Q1 CY2025 PAT at Rs. 26.15 crores
  • Huhtamaki India Ltd Q3 CY2024 net profit falls to Rs. 11.71 crores
  • Huhtamaki India Ltd Q2 CY2024 net profit surges to Rs. 38.54 crores
  • Huhtamaki India Ltd Q1CY24 net profit at Rs. 26.03 crores
  • AKI India Ltd enters into JV arrangement with NPS Shoes Ltd
  • Huhtamaki India Ltd Q3 CY2023 PAT rises to Rs. 32.27 crores
  • Huhtamaki India Ltd Q2CY23 PAT falls QoQ to Rs. 14.46 crores
  • AKI India Ltd Q1 FY2024 net profit at Rs. 30.82 lakhs
  • AKI India Ltd Q4 FY2023 consolidated profit lower at Rs. 23.14 lakhs
  • Huhtamaki India Ltd Q1CY23 net profit climbs to Rs. 35.49 crores
  • Huhtamaki India Limited recommends dividend of Rs. 2
  • Huhtamaki India Ltd Q4CY22 net profit increases to Rs. 16.84 crores
  • Huhtamaki India Ltd to monetize Land and Building at Majiwade, Thane
  • Huhtamaki India Ltd Q2CY22 net profit at Rs. 8.15 crores
  • Huhtamaki India Limited approves monetizing leasehold land and building
  • Huhtamaki India Q1CY22 PAT soars to Rs. 24.61 crores
  • Huhtamaki prints 12 million unique packs for the NestlĂ© KitKat #LoveBreak series
  • Huhtamaki India Awarded for 'Excellence in Packaging' at ET Polymers Excellence Award 2022
  • Huhtamaki India posts CY2021 loss of Rs. 22.69 crores
  • Huhtamaki India Ltd Board recommends Dividend of Rs. 1
  • Huhtamaki India Ltd reports Q3CY21 loss at Rs. 21.84 crore

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024